Oral Fat Tolerance Test in Male and Female C57BL/6 Mice

引用 收藏 提问与回复 分享您的反馈 被引用


Postprandial hyperlipidemia is an important risk factor for cardiovascular diseases, and it can be evaluated by an oral fat tolerance test (OFTT). There is no consensus on how to perform the OFTT in rodents, especially in the C57BL/6 mice strain. Furthermore, there is no consensus in the literature regarding several variables involved in the test (e.g., dietary lipid source and fasting duration), and consequently, there is no standardization for the OFTT protocol. Therefore, we aimed to demonstrate a protocol for OFTT in male and female C57BL/6 mice. Briefly, mice underwent a 2 h-fasting period followed by blood collection from the tail and orogastric gavage of 200 μl soybean oil. Blood was collected again at 1, 2, and 3 h after gavage, and centrifuged for triglyceride quantitation through a colorimetric enzymatic assay. Triglyceridemia was evaluated throughout the test, and the area under the curve was calculated. The present protocol contributes to standardizing the OFTT protocol in C57BL/6 mice and enables future research regarding the influence of sex and cardiometabolic diseases on postprandial lipemia.

Keywords: Fatty acids (脂肪酸), Lipid metabolism (类脂物代谢作用), Oral fat tolerance test (口服脂肪耐受性试验), Postprandial triglyceridemia (餐后高甘油三酯血症), Postprandial lipemia (餐后脂血症), Triglycerides (三酸甘油酯)


The amount of triglycerides (TG) produced in lipid metabolism has an important correlation with the onset and development of cardiometabolic diseases. Postprandial lipemia is an important cardiovascular risk biomarker since, among the usual blood lipid fractions analyzed, TG is the first to change after food intake (Nordestgaard, 2016). Recently, international associations recommended that fasting is no longer required for blood lipid analysis. It is justified firstly by the fact that individuals remain most of their time in a postprandial state, and secondly because there is no significant variation in TG between fed or fasted individuals (Nordestgaard et al., 2016). The oral fat tolerance test (OFTT) is a reliable method for assessing postprandial lipemia because it represents the body’s capacity to normalize hyperlipidemia after lipid intake, allowing a more profound analysis of lipid metabolism. The OFTT consists of giving a particular food and monitoring its metabolic response in the body (Langsted and Nordestgaard, 2011).

Animal models are essential for studying metabolism and cardiometabolic diseases; however, there is currently no consensus regarding how to perform the OFTT in rodents, and as a consequence, there is a wide range of variation among published OFTT protocols. A recent study demonstrated that OFTT results are influenced by mouse strain, dietary lipid source, fasting duration, and sex (Ochiai, 2020). Although Ochiai et al. indicated that other strains may have a better response in OFTT (Ochiai, 2020), C57BL/6 mice continue to be the most studied strain for cardiometabolic diseases (Fazio and Linton, 2001); therefore, it has become crucial to establish a protocol to assess postprandial lipemia in these animals.

The vast majority of OFTT studies performed in C57BL/6 mice use olive oil (Kimura et al., 2011 and 2013; Toyoda-Ono et al., 2007; Hiel et al., 2018; Sairyo et al., 2018); although, there are some reports with coconut (enriched with oleic acid) (Hernandez Vallejo et al., 2009), safflower (Yamazaki et al., 2012), and corn (King et al., 2010) oils. Ochiai et al. demonstrated that olive and soybean oils present similar OFTT results in ddY mice (Ochiai, 2020). It is also important to consider the amount of fat administered, since the dose reported in the literature ranges from 5 ml/kg to 17 ml/kg (Toyoda-Ono et al., 2007; King et al., 2010; Sairyo et al., 2018) and the volume ranges from 150 μl to 400 μl (Hernandez Vallejo et al., 2009; Kimura et al., 2011 and 2013; Yamazaki et al., 2012). In the face of this evidence, we propose an OFTT meal protocol of 200 μl soybean oil, which corresponds to approximately 7 ml/kg. We did not correct the oil volume by body weight because we noticed that body mass fluctuations within the range expected for this mouse strain did not significantly alter the volume of oil administered, and it is also difficult to measure precisely in the syringe.

The fasting duration can range from 4 h to 24 h (Toyoda-Ono et al., 2007; Hernandez Vallejo et al., 2009; King et al., 2010; Kimura et al., 2011 and 2013; Yamazaki et al., 2012; Sairyo et al., 2018). Considering that fasting is a stressful event for rodents (Choi et al., 2005) and current guidelines for humans suggest that fasting is no longer required for TG analysis (Nordestgaard et al., 2016), we propose a short fasting protocol of 2 h. Lastly, sex should also be considered, since most studies are conducted in male mice (Toyoda-Ono et al., 2007; Hernandez Vallejo et al., 2009; King et al., 2010; Kimura et al., 2011 and 2013; Yamazaki et al., 2012; Hiel et al., 2018; Sairyo et al., 2018). Ochiai et al. showed that females are less prone to lipid-induced hypertriglyceridemia; however, these results were reported only in ddY mice (Ochiai, 2020), thus, we chose to propose a protocol for male and female mice.

Another two important factors to consider are the frequency and timing of blood sampling and mouse metabolic background. Concerning the former, the TG peak would appear between 2 h and 3 h after lipid administration (Yamazaki et al., 2012; Sairyo et al., 2018; Ochiai, 2020). Regarding the latter, some studies conducted the OFTT in high fat-fed mice, while others were performed in healthy mice. According to Ochiai et al., high-fat and high-sucrose feeding for one week is sufficient to promote lipid-induced hypertriglyceridemia during the OFTT (Ochiai, 2020).

Based on these data, we aimed to demonstrate a protocol for OFTT in male and female C57BL/6 mice using 200 μl soybean oil after a 2-h fasting period.

Materials and Reagents

  1. 96-well plates for 0.3 ml volume with flat-bottomed wells (Olen, catalog number: K30-5096P)

  2. 1-ml slip tip disposable tuberculin syringe (BD, catalog number: 309659)

  3. Disposable scalpel blade (Solidor, model #10, Brazil)

  4. 0.5-ml microtube (AxygenTM, catalog number: 14-222-292)

  5. Pipette tips (P-10, P-100, P-200) (Labmate, Saint Albans, UK)

  6. Mouse restrainer (Insight, catalog number: EB286CO)

  7. Paper towel

  8. Sterile gauze

  9. Adult C57BL/6 mice (≥ 3 months old)

  10. Soybean oil (Liza, Curitiba, Brazil)

  11. Ultrapure water (MilliQ® Direct Water Purification System, Merck, Darmstadt, Germany)

  12. Ice

  13. Triglyceride reagent kit (catalog #26B, Interteck, São Paulo, Brasil, GPO/PAP)


  1. Ventilated cages (Scienlabor, catalog number: SLB50.56)

  2. Reusable curved animal feeding needle (Cadence ScienceTM, model: 01-290-9A)

  3. Microtube rack (AxygenTM, model: 14-222-391)

  4. Refrigerated centrifuge (Cientec, model: CT-1500)

  5. Vortex mixer (IKA, model: K45-2820)

  6. Water bath (Novatecnica, model: NT-245)

  7. Epoch UV-visible light spectrophotometer (BioTek® Instruments, Vermont, USA)

  8. Refrigerator (Consul, CRD37EBANA, São Paulo, Brazil)


  1. Gen5TM Microplate Data Collection & Analysis Software (BioTek® Instruments, Vermont, USA)

  2. Microsoft Excel (Microsoft, Redmond, Washington, EUA)

  3. GraphPad Prism v.8.0 (GraphPad Software, San Diego, California, USA)


  1. Animal housing conditions

    Prior to the procedures, animals were maintained in ventilated cages (Scienlabor, Ribeirão Preto, São Paulo, Brazil) under controlled conditions of 21±1°C, 60±10% humidity, 15 min/h exhaustion, and 12 h dark/light cycle (artificial lights, 7am-7pm).

  2. Oral fat tolerance test (OFTT) (Figure 1)

    1. Fast the mice for 2 h.

    2. Cut the tip (1 mm) off the tail with a scalpel blade.

    3. Milk the tail and collect the blood drops using a pipette (P10).

    4. Dispense the blood in a 0.5-ml microtube.

    5. Repeat the process to obtain about 20 μl blood (~4 blood drops).

    6. Perform orogastric gavage of 200 μl soybean oil in each animal (video showing the procedure: https://youtu.be/oYCmKIhveFY).

    7. Take 20 μl blood from the tail (~4 blood drops) using a pipette (P10) at 1 h, 2 h, and 3 h after orogastric gavage.

      Note: If the original tail cut is healed or has a blood clot, remove the blood clot or cut the tip (1 mm) off the tail with a scalpel blade.

    8. Store the blood in a 0.5-ml microtube at room temperature for 20 min and then on ice until centrifugation.

    9. Centrifuge blood samples (800 × g for 10 min).

    10. Reserve the serum in a new 0.5-ml microtube.

      Note: Keep it on ice if the assay is performed on the same day or store it in the refrigerator at 4°C (for up to one month) until the biochemical assay.

      Figure 1. Oral fat tolerance test (OFTT). Image created in BioRender.com.

  3. Biochemical analysis (Tables 1 and 2)

    1. Remove the serum from the refrigerator and keep it on ice or in a thermal bag throughout the assay.

    2. Reserve the TG reagent kit, which consists of a control sample (100 mg/dl) and a working reagent, and allow them to equilibrate to room temperature (for reagent composition, see Table 1).

    3. Prepare controls #1, #2, and #3 by diluting the control sample provided in the kit, which will be used later to obtain the standard curve equation (see Table 2).

      1. Use three controls: the one provided in the kit (control #1) and two further concentrations (controls #2 and #3).

      2. Dilute the control sample with ultrapure water at concentrations of 1:2 and 1:4.

    4. Organize sample disposition in the 96-well plate.

      1. Include blank and control samples in triplicate and test samples in duplicate.

    5. Pipette 200 μl working reagent in all wells.

    6. Pipette 2 μl ultrapure water in blank wells (triplicate).

    7. Pipette 2 μl either control (triplicate) or samples of unknown concentration in the corresponding well (duplicates).

      Note: Use a vortex to homogenize the sample before pipetting.

    8. Incubate the microplate in a water bath at 37°C for 10 min.

    9. Perform microplate reading in the light spectrophotometer at a wavelength of 505 nm and area scan 5 × 5.

      Table 1. TG reagent kit composition*

      Kit reagent Composition
      Control sample
      • 2.26 mmol/l Glycerol
      • 0.1 g/dl Sodium azide
      Working reagent
      • 50 mmol/L PIPES buffer pH 7.0
      • ≥ 4,000 U/L Lipoprotein lipase
      • 2 mmol/l ATP
      • 0.3 mmol/l 4-Aminoantipyrine
      • ≥ 1,000 U/L Glycerol kinase
      • ≥ 3,000 U/L Glycerol phosphate oxidase
      • ≥ 2,010 U/L Peroxidase
      • 2.70 mmol/L p-Chlorophenol
      • 0.95 g/dl Sodium azide

      * According to the manufacturer.

      Table 2. Assay reaction

      Samples of unknown concentration triglyceride
      Blank 200.0 µl - 2.0 µl - 0.0 mg/dl
      Control #1 200.0 µl 2.0 µl - - 100.0 mg/dl
      Control #2 200.0 µl 1.0 µl 1.0 µl - 50.0 mg/dl
      Control #3 200.0 µl 0.5 µl 1.5 µl - 25.0 mg/dl
      Sample 200.0 µl - - 2.0 µl unknown

      Absorbance of controls #1, #2, and #3 will be used to calculate the standard curve equation.

Data analysis

  1. Calculations

    1. Average absorbance: The 5 × 5 reading will generate 21 readings for each well. First, remove the readings that correspond to the well border (columns #1 and #5, lines #1 and #5) and then calculate the average absorbance for each well. The reason is that the TG reagent sometimes produces bubbles that are trapped at the well edge, increasing the average well absorbance since the equipment reading is performed along the vertical axis. Subsequently, calculate the average absorbance of triplicates/duplicates of each control and test samples.

    2. To calculate triglyceride concentration: First, calculate the standard curve equation from the control samples using linear regression. In GraphPad Prism, choose the ‘XY table’ and plot the control sample concentration (X) against absorbance (Y). Run the linear regression analysis and find the curve equation (Y = aX + b, where the statistical software provides ‘a’ and ‘b’). For an example of the standard curve, please see Figure 2. Subsequently, in Microsoft Excel, calculate the unknown sample TG concentration (mg/dl) by substituting ‘Y’ in the equation with sample absorbance.

      Figure 2. Example of the standard curve. In the graph, the control sample concentration (X) and absorbance (Y) are plotted. Control sample concentrations consist of the one provided with the kit (100 mg/dL) and two other dilutions (1:2 and 1:4). The absorbances were obtained by reading in the light spectrophotometer at a wavelength of 505 nm. Linear regression analysis was performed to find the curve equation (Y = aX + b). Goodness of the fit of linear regression: R2 = 0.9998; Sy·x = 0.0005345.

    3. OFTT curve: In GraphPad Prism, use the ‘XY table’ to plot the TG time–response curve. Time in hours (X) is plotted against TG concentration in mg/dl (Y). Use the mean and standard deviation of the TG concentration of the control and experimental groups.

    4. OFTT net incremental area under the curve (AUC): Includes all the incremental area below the curve, including the area below the fasting concentration. It is calculated using the trapezoidal rule for positive and negative increments (Gannon et al., 1989). In GraphPad Prism, create a ‘XY table,’ add the time (0, 1, 2, and 3 h) in the ‘X’ column and TG in the ‘Y’ column (one animal per column, use one table to add data from one experimental group), and run the ‘analyze > area under the curve.’ Subsequently, copy the data ‘total area’ from the results sheet and paste it to a new ‘column table,’ where each column is an experimental group, to run the appropriate statistical test for group comparisons.

    5. OFTT incremental area under the curve (iAUC): The iAUC includes all areas below the curve and above the fasting concentration, with any area beneath fasting being ignored (Wolever and Jenkins, 1986). In GraphPad Prism, create an ‘XY table,’ plot time (0, 1, 2, and 3 h) in the ‘X’ column and TG in the ‘Y’ column (one animal per table). Run the ‘analyze > area under the curve,’ and in the dialogue box, type the TG concentration for that mouse at time 0 h in the ‘Baseline Y = ’ box. Subsequently, copy the data ‘total peak area’ from the results sheet and paste it to a ‘column table,’ where each column is an experimental group, for group comparisons.

  2. Data obtained

    Herein, we show our results for the OFTT (Figure 3), body mass, and glucose (Figure 4). We used saline as a negative control for the OFTT, but this comparison is not required when using the test to evaluate postprandial lipemia. Moreover, we also reported the changes in body mass and glycemia during the OFTT so readers are aware that while there is a reduction in body mass, blood glucose is not altered during the test. The glucose AUC was calculated by applying the same steps described for the OFTT AUC.

    For OFTT, we compared time intervals in the same group and the groups at each time point. We also evaluated the TG AUC and iAUC and differences (ΔTG) at 1 h vs. 0 h and 2 h vs 0 h. In males, the TG of the soybean group at 3 h was reduced by 19% in comparison with that at 2 h. In females, the TG at 2 h was increased by 29% with soybean oil as compared with saline. Soybean oil elevated the TG AUC (+24%) and iAUC (+911%) at Δ1 h vs. 0 h and Δ2 h vs. 0 h.

    Figure 3. Oral fat tolerance test (OFTT). (a) Triglyceride (TG) response curve during the OFTT in mg/dl. In (b) and (c), the area under the curve (AUC) and the incremental AUC (iAUC) were calculated for group comparisons. In (d) and (e), the TG response from 0 h until the first (d) and second (e) hours are presented.

    Figure 4. Body mass and glucose. (a) Body mass of male and female C57BL/6 mice assessed before a 2h-fasting and at the end of the OFTT. They lost 7.0 ± 1.6% (male) and 8.6 ± 0.9% (female) of their body mass during this time range. (b) The area under the curve (AUC) of glucose was not changed by saline or soybean oil during the OFTT.


Caution has to be taken during blood collection because successive tail milking may lead to blood hemolysis. It is also important to control the room temperature so that the body temperature of the mice is stable, otherwise the amount of blood collected is insufficient for biochemical assays. Mice of different sexes, ages, and inbred backgrounds can show different responses to OFTT. The protocol was performed in control female and male mice; thus it is important to establish the OFTT response in diet-induced obesity models. Lastly, in theory, other lipids could be assessed by the OFTT. Nevertheless, studies show that TG present relevant acute variations in the blood after food intake and thus, studying postprandial TG is important for predicting the presence of risk factors for cardiovascular diseases (Lopez-Miranda et al., 2007; Ochiai, 2020). Based on these data, researchers should be aware of analyzing other lipids in the OFTT before including the test in their procedures.


This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES; scholarship to LGR); Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq; scholarship to DFM); and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (Faperj; scholarship to CVALC and grant n° E-26/200.964/2017 - Apoio Emergencial para os Programas e Cursos de Pós-Graduação Stricto Sensu do Estado do Rio de Janeiro).

Competing interests

The authors have no competing interests to declare.


The experiments were approved by the local Ethics Committee (Fluminense Federal University, protocol number 920/2017).


  1. Choi, C. H., Zimon, A. and Usheva, A. (2005). Metabolic stress regulates basic transcription through acetyl-coenzyme A. Cell Mol Life Sci 62(6): 625-628.
  2. Fazio, S. and Linton, M. F. (2001). Mouse models of hyperlipidemia and atherosclerosis. Front Biosci 6: D515-525.
  3. Gannon, M. C., Nuttall, F. Q., Westphal, S. A., Neil, B. J. and Seaquist, E. R. (1989). Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects. Diabetes Care 12(8): 544-552.
  4. Hernandez Vallejo, S. J., Alqub, M., Luquet, S., Cruciani-Guglielmacci, C., Delerive, P., Lobaccaro, J. M., Kalopissis, A. D., Chambaz, J., Rousset, M. and Lacorte, J. M. (2009). Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet. Am J Physiol Gastrointest Liver Physiol 296(4): G782-792.
  5. Hiel, S., Neyrinck, A. M., Rodriguez, J., Pachikian, B. D., Bouzin, C., Thissen, J. P., Cani, P. D., Bindels, L. B. and Delzenne, N. M. (2018). Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine. Nutrients 10(5).
  6. Kimura, R., Takahashi, N., Lin, S., Goto, T., Murota, K., Nakata, R., Inoue, H. and Kawada, T. (2013). DHA attenuates postprandial hyperlipidemia via activating PPARalpha in intestinal epithelial cells. J Lipid Res 54(12): 3258-3268.
  7. Kimura, R., Takahashi, N., Murota, K., Yamada, Y., Niiya, S., Kanzaki, N., Murakami, Y., Moriyama, T., Goto, T. and Kawada, T. (2011). Activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes. Biochem Biophys Res Commun 410(1): 1-6.
  8. King, A. J., Segreti, J. A., Larson, K. J., Souers, A. J., Kym, P. R., Reilly, R. M., Collins, C. A., Voorbach, M. J., Zhao, G., Mittelstadt, S. W. and Cox, B. F. (2010). In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia. Eur J Pharmacol 637(1-3): 155-161.
  9. Langsted, A. and Nordestgaard, B. G. (2011). Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 57(3): 482-489.
  10. Lopez-Miranda, J., Williams, C. and Lairon, D. (2007). Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 98(3): 458-473.
  11. Nordestgaard, B. G. (2016). Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. Circ Res 118(4): 547-563.
  12. Nordestgaard, B. G., Langsted, A., Mora, S., Kolovou, G., Baum, H., Bruckert, E., Watts, G. F., Sypniewska, G., Wiklund, O., Boren, J., Chapman, M. J., Cobbaert, C., Descamps, O. S., von Eckardstein, A., Kamstrup, P. R., Pulkki, K., Kronenberg, F., Remaley, A. T., Rifai, N., Ros, E., Langlois, M., European Atherosclerosis, S., the European Federation of Clinical, C. and Laboratory Medicine Joint Consensus, I. (2016). Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European FederatClin Chem 62(7): 930-946.
  13. Ochiai, M. (2020). Evaluating the appropriate oral lipid tolerance test model for investigating plasma triglyceride elevation in mice. PLoS One 15(10): e0235875.
  14. Sairyo, M., Kobayashi, T., Masuda, D., Kanno, K., Zhu, Y., Okada, T., Koseki, M., Ohama, T., Nishida, M., Sakata, Y. and Yamashita, S. (2018). A Novel Selective PPARalpha Modulator (SPPARMalpha), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice. J Atheroscler Thromb 25(10): 1086.
  15. Toyoda-Ono, Y., Yoshimura, M., Nakai, M., Fukui, Y., Asami, S., Shibata, H., Kiso, Y. and Ikeda, I. (2007). Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols. Biosci Biotechnol Biochem 71(4): 971-976.
  16. Wolever, T. M. and Jenkins, D. J. (1986). The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr 43(1): 167-172.
  17. Yamazaki, T., Kishimoto, K. and Ezaki, O. (2012). The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat. J Lipid Res 53(10): 2024-2037.
Copyright: © 2021 The Authors; exclusive licensee Bio-protocol LLC.
How to cite: Rodrigues, L. G., Lutterbach-de-Carvalho, C. V. A., Motta, D. F., Fernandes-Santos, C. and Bargut, T. C. L. (2021). Oral Fat Tolerance Test in Male and Female C57BL/6 Mice. Bio-101: e4062. DOI: 10.21769/BioProtoc.4062.

如果您对本实验方案有任何疑问/意见, 强烈建议您发布在此处。我们将邀请本文作者以及部分用户回答您的问题/意见。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片的形式来说明遇到的问题。

如果您对本实验方案有任何疑问/意见, 强烈建议您发布在此处。我们将邀请本文作者以及部分用户回答您的问题/意见。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片的形式来说明遇到的问题。